Project Grant R01AG083894
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded University of California, Davis a $690,934 project grant effective March 1, 2026, through November 30, 2030, under the Aging Research program (CFDA 93.866). The grant supports a comprehensive research initiative examining subjective cognitive decline (SCD) as an early risk indicator for Alzheimer's disease and related dementias (AD/ADRD) across diverse racial and ethnic populations. The project addresses a critical...
- Federal Project Grant Award Summary The National Institute on Aging awarded a $123,876 Project Grant to the University of California, Los Angeles (UCLA) Office of Research Administration on March 15, 2026, under the Aging Research program (CFDA 93.866) with a completion date of February 29, 2028. This research initiative investigates the occupational determinants of cognitive and brain health among middle-aged and older Latino populations in the United States. The project addresses a critical...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $3.22 million Project Grant under the Aging Research program (CFDA 93.866) to the University of California, Irvine on September 15, 2025, for research investigating the role of the retrosplenial cortex (RSC) in Alzheimer's disease (AD) pathogenesis. The project, which extends through August 31, 2029, will deliver scientific research products including characterization of neuronal hyperexcitability mechanisms in...
- Federal Grant Award Summary The National Institute on Aging (CFDA 93.866 – Aging Research) awarded University of California, Irvine a $6.26 million Project Grant effective September 1, 2025, through June 30, 2030, to establish a Discovery and Trial Ready Cohort for Limbic Predominant Age-Related TDP-43 Encephalopathy (TRC LATE). The project addresses critical gaps in diagnostic validation, biomarker development, and recruitment strategies for LATE, a common neuropathologic change affecting...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $3.42 million Project Grant to the University of California, Davis on September 15, 2025, under the Aging Research program (CFDA 93.866) to support research on capturing social and cognitive health dynamics as digital risk biomarkers of Alzheimer's Disease and related dementias (AD/ADRDS). The project, which extends through September 14, 2029, addresses critical gaps in understanding how poor social...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded University of California, San Diego $3,138,871 under the Aging Research program (CFDA 93.866) to conduct a comprehensive four-year research project examining human neuropeptide transmitter systems in Alzheimer's disease (AD) pathogenesis. The project, initiated September 15, 2025 and concluding August 31, 2029, will deliver scientific research services focused on defining the complete repertoire of human brain...
- Federal Grant Award Summary The University of California, Los Angeles (UCLA) received a $643,139 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) for the TARDIS-AD project, awarded on September 30, 2025, with completion scheduled for August 31, 2027. This research initiative will deliver a comprehensive scientific analysis identifying personalized, cost-effective intervention strategies to reduce disparities in Alzheimer's disease and related...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $1,450,964 Project Grant to The Regents of the University of California, Berkeley, under the Aging Research program (CFDA 93.866) to develop novel statistical methodologies for understanding heterogeneous causal pathophysiology of Alzheimer's disease (AD). The award, issued May 15, 2025, with completion targeted for February 28, 2030, addresses a critical gap in understanding how and when amyloid-beta-lowering...
- Federal Grant Award Summary The National Institute on Aging awarded The Leland Stanford Junior University a $165,888 Project Grant on August 15, 2025, under the Aging Research program (CFDA 93.866) to conduct research on neuroimaging and genetics of the glymphatic system in Alzheimer's disease through May 31, 2030. The research will deliver novel, non-invasive diagnostic markers characterizing the brain's glymphatic system—its waste clearance mechanism—by combining three complementary...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Icahn School of Medicine at Mount Sinai a $8.07 million Project Grant under the Aging Research program (CFDA 93.866) to examine unique markers and risk factors for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) in foreign- and native-born older Chinese Americans. The five-year research initiative, awarded on September 15, 2025, and scheduled for completion by August 31, 2030, will investigate the...
The National Institute on Aging (NIA) awarded a $3.52 million Project Grant to the University of California, Davis, under the Aging Research program (CFDA 93.866) to conduct longitudinal magnetic resonance imaging (MRI) studies examining cerebrovascular injury and Alzheimer's disease atrophy in Latino populations. The award, obligated on March 15, 2026, with a completion date of November 30, 2030, funds the continuation phase of the "Longitudinal MRI Measures of Cerebrovascular Injury and AD Atrophy in a Study of Latinos (SOL-INCA-MRI Long)" initiative. This research builds upon the initial cycle's successful acquisition of brain MRI data from 2,668 participants in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort, which provided cross-sectional findings on brain structure, vascular risk factors, sleep impacts, cognitive associations, and genetic influences on brain measures. The longitudinal study addresses a critical research gap by investigating normal cognitive aging, mild cognitive impairment, and Alzheimer's disease and related dementias (ADRD) in a representative Latino population—a demographically significant and underrepresented group in biomarker research. By tracking participants over time, the research aims to identify biological mechanisms underlying cognitive decline and dementia in Latinos, who experience higher prevalence of vascular risk factors and a greater likelihood of non-Alzheimer's disease cognitive impairment compared to non-Hispanic white populations. The study's findings are intended to inform prevention strategies and enhance diagnosis and treatment approaches tailored to Latino communities.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $3.5m | 3/5/26 |